No recent ownership filings for this insider.
| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | Dec 11, 2025 | REGENERON PHARMACEUTICALS, INC. | CEO | Sell | 15.0 | -155,145 | -18.40% | ✗ | $108.8M |
| Jun 11, 2024 | Jun 13, 2024 | REGENERON PHARMACEUTICALS, INC. | CEO | Sell | 30.0 | -25,213 | -3.62% | ✓ | $25.6M |
| Jun 6, 2024 | Jun 10, 2024 | REGENERON PHARMACEUTICALS, INC. | CEO | Sell | 47.5 | -787 | -0.11% | ✓ | $798.8K |
| May 17, 2024 | May 17, 2024 | REGENERON PHARMACEUTICALS, INC. | CEO | Sell | 30.0 | -22,830 | -3.18% | ✓ | $22.4M |
| May 13, 2024 | May 15, 2024 | REGENERON PHARMACEUTICALS, INC. | CEO | Sell | 7.5 | -180,374 | -20.07% | ✓ | $176.3M |
| Dec 11, 2023 | Dec 13, 2023 | REGENERON PHARMACEUTICALS, INC. | CEO | Sell | 15.0 | -12,841 | -1.81% | ✗ | $10.8M |
| Apr 5, 2022 | Apr 7, 2022 | REGENERON PHARMACEUTICALS, INC. | CEO | Sell | 38.8 | -7,114 | -1.03% | ✓ | $5.1M |
| Mar 31, 2022 | Apr 4, 2022 | REGENERON PHARMACEUTICALS, INC. | CEO | Sell | 43.8 | -2,886 | -0.42% | ✓ | $2M |
| Nov 19, 2021 | Nov 19, 2021 | REGENERON PHARMACEUTICALS, INC. | CEO | Sell | 15.0 | -359,137 | -25.25% | ✗ | $234.1M |
| Aug 18, 2021 | Aug 20, 2021 | REGENERON PHARMACEUTICALS, INC. | CEO | Sell | 2.5 | -210,000 | -28.31% | ✓ | $136.6M |
| Aug 16, 2021 | Aug 17, 2021 | REGENERON PHARMACEUTICALS, INC. | CEO | Sell | 38.8 | -10,000 | -1.33% | ✓ | $6.2M |
| Aug 6, 2021 | Aug 10, 2021 | REGENERON PHARMACEUTICALS, INC. | CEO | Sell | 12.5 | -228,575 | -16.14% | ✓ | $138.9M |
| May 11, 2020 | May 13, 2020 | REGENERON PHARMACEUTICALS, INC. | CEO | Sell | 33.8 | -312,500 | -2.35% | ✓ | $178.2M |
| Dec 12, 2019 | Dec 13, 2019 | REGENERON PHARMACEUTICALS, INC. | CEO | Sell | 17.5 | -161,963 | -14.38% | ✓ | $61.1M |
| Dec 13, 2018 | Dec 14, 2018 | REGENERON PHARMACEUTICALS, INC. | CEO | Sell | 12.5 | -160,131 | -16.81% | ✓ | $60.4M |
| Dec 13, 2017 | Dec 13, 2017 | REGENERON PHARMACEUTICALS, INC. | CEO | Sell | 2.5 | -135,816 | -32.87% | ✓ | $52.3M |
| Dec 15, 2016 | Dec 19, 2016 | REGENERON PHARMACEUTICALS, INC. | CEO | Sell | 2.5 | -135,397 | -45.36% | ✓ | $51.5M |